Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30

Body weight (BW) excess is a characteristic problem for type 2 diabetes mellitus (T2DM) both as its pathogenetic feature and as a side effect of blood glucose lowering therapy. In the latter case reduction of glycosuria and frequent hypoglycemic events are primarily blamed for BW gain, but additiona...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Elena Viktorovna Surkova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2013
Materias:
Acceso en línea:https://doaj.org/article/f7819690429c457ab589d052cfd31b4b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!